Integrative molecular analysis of metastatic hepatocellular carcinoma.
Dongfang WangYanjing ZhuJing TangQiuyu LianGuijuan LuoWen WenMichael Q ZhangHongyang WangLei ChenJin GuPublished in: BMC medical genomics (2019)
The metastatic HCCs with PVTTs have significant molecular alterations comparing with adjacent normal tissues. The recurrent alteration patterns are similar to several previously published general HCC cohorts, but usually with higher severity. By an individualized differential analysis strategy, the progressively differentially expressed genes between the primary tumor and PVTT were identified for each patient. A few patients aquire evidential progressive alterations of gene expressions. And, experiments show that several recurrently differentially expressed genes can strongly regulate HCC cell invasions.
Keyphrases
- genome wide
- end stage renal disease
- squamous cell carcinoma
- small cell lung cancer
- genome wide identification
- newly diagnosed
- ejection fraction
- chronic kidney disease
- multiple sclerosis
- gene expression
- randomized controlled trial
- peritoneal dialysis
- systematic review
- single cell
- bioinformatics analysis
- cell therapy
- single molecule
- transcription factor
- bone marrow
- mesenchymal stem cells